4//SEC Filing
TOWSE MATTHEW W 4
Accession 0001246360-17-002802
CIK 0001333170other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 7:07 PM ET
Size
8.0 KB
Accession
0001246360-17-002802
Insider Transaction Report
Form 4
TOWSE MATTHEW W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-09-20$14.05/sh+4,300$60,415→ 28,721 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-09-20−4,300→ 4,030 totalExercise: $14.05From: 2014-07-15Exp: 2023-07-14→ Common Stock (4,300 underlying) - Sale
Common Stock
2017-09-20$27.27/sh−4,300$117,261→ 24,421 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001195852
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 7:07 PM ET
- Size
- 8.0 KB